Diasio RB - Search Results

1

Capecitabine induces rapid, sustained response in two patients with extensive oral verrucous carcinoma.

Salesiotis A, Soong R, Diasio RB, Frost A, Cullen KJ. Salesiotis A, et al. Among authors: diasio rb. Clin Cancer Res. 2003 Feb;9(2):580-5. Clin Cancer Res. 2003. PMID: 12576421

2

Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy.

Jiang W, Lu Z, He Y, Diasio RB. Jiang W, et al. Among authors: diasio rb. Clin Cancer Res. 1997 Mar;3(3):395-9. Clin Cancer Res. 1997. PMID: 9815697

3

Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.

Johnson MR, Hageboutros A, Wang K, High L, Smith JB, Diasio RB. Johnson MR, et al. Among authors: diasio rb. Clin Cancer Res. 1999 Aug;5(8):2006-11. Clin Cancer Res. 1999. PMID: 10473079

4

Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB, Danenberg PV. Salonga D, et al. Among authors: diasio rb. Clin Cancer Res. 2000 Apr;6(4):1322-7. Clin Cancer Res. 2000. PMID: 10778957 Clinical Trial.

5

Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics.

Mattison LK, Soong R, Diasio RB. Mattison LK, et al. Among authors: diasio rb. Pharmacogenomics. 2002 Jul;3(4):485-92. doi: 10.1517/14622416.3.4.485. Pharmacogenomics. 2002. PMID: 12164772 Review.

6

Denaturing high performance liquid chromatography analysis of the DPYD gene in patients with lethal 5-fluorouracil toxicity.

Ezzeldin H, Johnson MR, Okamoto Y, Diasio R. Ezzeldin H, et al. Clin Cancer Res. 2003 Aug 1;9(8):3021-8. Clin Cancer Res. 2003. PMID: 12912951

7

Simultaneous detection of variable number tandem repeats, single nucleotide polymorphisms, and allelic imbalance in the thymidylate synthase gene enhancer region using denaturing high-performance liquid chromatography.

Ezzeldin H, Hoffmayer C, Soong R, Johnson MR, Lee A, Heslin M, Diasio R. Ezzeldin H, et al. Anal Biochem. 2004 Nov 15;334(2):276-83. doi: 10.1016/j.ab.2004.07.025. Anal Biochem. 2004. PMID: 15494134

8

Phase II evaluation of docetaxel-modulated capecitabine in previously treated patients with non-small cell lung cancer.

Kindwall-Keller T, Otterson GA, Young D, Neki A, Criswell T, Nuovo G, Soong R, Diasio R, Villalona-Calero MA. Kindwall-Keller T, et al. Clin Cancer Res. 2005 Mar 1;11(5):1870-6. doi: 10.1158/1078-0432.CCR-04-1727. Clin Cancer Res. 2005. PMID: 15756012 Clinical Trial.

9

Advances and challenges in fluoropyrimidine pharmacogenomics and pharmacogenetics.

Soong R, Diasio RB. Soong R, et al. Among authors: diasio rb. Pharmacogenomics. 2005 Dec;6(8):835-47. doi: 10.2217/14622416.6.8.835. Pharmacogenomics. 2005. PMID: 16296946 Review.

10

Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.

Blanquicett C, Saif MW, Buchsbaum DJ, Eloubeidi M, Vickers SM, Chhieng DC, Carpenter MD, Sellers JC, Russo S, Diasio RB, Johnson MR. Blanquicett C, et al. Among authors: diasio rb. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8773-81. doi: 10.1158/1078-0432.CCR-05-0627. Clin Cancer Res. 2005. PMID: 16361565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters